EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice

He Huang iD, Xiaojing Dong, Zuoyuan Du, Li Guo, Lan Chen, Xinming Wang, Simin Lu, Kun Yue, Zhihong Ren, Jianwei Wang iD, Lili Ren, Jianguo Xu iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.01603-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von He Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of System Biology of Pathogens and Christophe Mérieux Laboratory, National Institute of Pathogen Biology, Chinese Academy of Medic…. Hauptthemen laut MEDLINE: Lactiplantibacillus plantarum, Probiotics, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), The CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets epithelial cells in the respiratory tract, triggering an acute proinflammatory response and chronic lung inflammation. Probiotic supplementation has shown promise in reducing the nasopharyngeal SARS-CoV-2 viral load, diminishing symptom frequency and duration, and mitigating inflammation; thus, it is a potential strategy for treating coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2 infection. In this study, we evaluated the effects of the oral administration of the Lactobacillus plantarum GUANKE strain, a gram-positive bacterium originally isolated from a healthy individual, on SARS-CoV-2 infection in a human ACE2 transgenic mouse model. We found that GUANKE significantly reduced inflammatory cell infiltration and pulmonary interstitial exudation in mice. The transcription of CCL2 , TNFA , IL1B , IL6, and IL17C in the lungs was reduced. The protein levels of TNF-α, IL-1β, IL-6, and IL-17 in the lungs were significantly lower in GUANKE-treated mice than in control mice. The viral load in GUANKE-treated mice was lower than that in saline-treated mice, although this difference did not reach statistical significance. L. plantarum GUANKE can decrease SARS-CoV-2-induced lung inflammation in mice, suggesting its potential for use as an agent for treating SARS-CoV-2 infection. IMPORTANCE Most otherwise healthy individuals develop only mild or moderate symptoms of coronavirus disease 2019 (COVID-19) caused by current strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and virus replication is mainly confined to the upper respiratory tract; however, the virus can infect the lower respiratory tract and promote inflammation. Probiotic supplementation has been shown to reduce nasopharyngeal SARS-CoV-2 viral load, reduce the overall number and duration of symptoms, and attenuate inflammation in clinical trials. We showed that a novel L. plantarum GUANKE strain alleviated SARS-CoV-2-induced pneumonia in mice. The transcription and production of inflammatory cytokines were suppressed, and GUANKE moderately reduced the viral load. L. plantarum GUANKE has the potential to become a candidate drug for the treatment of COVID-19 or other viral respiratory infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactiplantibacillus plantarumProbioticsSARS-CoV-2COVID-19COVID-19 Drug TreatmentAnimalsMiceViral LoadDisease Models, AnimalHumansLungCytokinesMice, TransgenicAngiotensin-Converting Enzyme 2MaleFemale

Stichwörter der Autor:innen

LactobacillusSARS-CoV-2antiviralinflammationprobiotics

Substanzen

CytokinesAngiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • NHC Key Laboratory of System Biology of Pathogens and Christophe Mérieux Laboratory, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Ch…
  • Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: He Huang, Jianwei Wang, Jianguo Xu

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)
  • The CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Huang, H., Dong, X., Du, Z., Guo, L., Chen, L., Wang, X., Lu, S., Yue, K., Ren, Z., Wang, J., Ren, L., & Xu, J. (2024). Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01603-24

Vancouver

Huang H, Dong X, Du Z, Guo L, Chen L, Wang X, et al. Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01603-24

BibTeX
@article{Huang2024,
  author = {Huang, He and Dong, Xiaojing and Du, Zuoyuan and Guo, Li and Chen, Lan and Wang, Xinming and Lu, Simin and Yue, Kun and Ren, Zhihong and Wang, Jianwei and Ren, Lili and Xu, Jianguo},
  title = {Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.01603-24}
}
Kostenlos starten →